Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model

Breast cancer is the most common malignancy in women of the Western world. Doxorubicin (DOX) continues to be used extensively to treat early-stage or node-positive breast cancer, human epidermal growth factor receptor-2 (HER2)-positive breast cancer, and metastatic disease. We have previously demons...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Chhanda, Awasthi, Sanjay, Sharma, Rajendra, Beneš, Helen, Hauer-Jensen, Martin, Boerma, Marjan, Singh, Sharda P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843244/
https://www.ncbi.nlm.nih.gov/pubmed/29518137
http://dx.doi.org/10.1371/journal.pone.0193918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843244/
https://www.ncbi.nlm.nih.gov/pubmed/29518137
http://dx.doi.org/10.1371/journal.pone.0193918

Ejemplares similares